These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 9812619)
1. [Analysis of mutation types of p53 gene and possible carcinogenic factors in lung cancer]. Gao ZQ; Gao Z; Zhang X Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Mar; 31(2):88-91. PubMed ID: 9812619 [TBL] [Abstract][Full Text] [Related]
2. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer. Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268 [TBL] [Abstract][Full Text] [Related]
3. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113 [TBL] [Abstract][Full Text] [Related]
4. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
5. [PCR-SSCP and sequencing analysis on mutations of anti-oncogene p53 in asbestos-related lung cancer]. Fu D; Liu B; Miao Q; Wang H Wei Sheng Yan Jiu; 1997 Sep; 26(5):289-92. PubMed ID: 10325638 [TBL] [Abstract][Full Text] [Related]
6. [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer]. Zhang J; Zheng J; Fang W Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):846-9. PubMed ID: 11038779 [TBL] [Abstract][Full Text] [Related]
7. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients. Murata M; Tagawa M; Kimura H; Kakisawa K; Shirasawa H; Fujisawa T Int J Oncol; 1998 Mar; 12(3):577-81. PubMed ID: 9472095 [TBL] [Abstract][Full Text] [Related]
8. [A preliminary study on p53 gene in lung cancer tissues of workers exposed to silica and welding fumes]. Liu B; Zhou P; Miao Q Zhonghua Yu Fang Yi Xue Za Zhi; 1997 May; 31(3):153-6. PubMed ID: 9812593 [TBL] [Abstract][Full Text] [Related]
9. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis. de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838 [TBL] [Abstract][Full Text] [Related]
10. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients. Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123 [TBL] [Abstract][Full Text] [Related]
11. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer. Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767 [TBL] [Abstract][Full Text] [Related]
12. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma. Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567 [TBL] [Abstract][Full Text] [Related]
13. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas. Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037 [TBL] [Abstract][Full Text] [Related]
14. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis. Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937 [TBL] [Abstract][Full Text] [Related]
15. A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients. Kondo K; Tsuzuki H; Sasa M; Sumitomo M; Uyama T; Monden Y J Surg Oncol; 1996 Jan; 61(1):20-6. PubMed ID: 8544455 [TBL] [Abstract][Full Text] [Related]
16. [Detection of K-ras oncogene mutations in human lung cancer by PCR-SSCP-DNA direct sequencing]. Fang Q; Li X; Li J; Liang S Wei Sheng Yan Jiu; 1998 Jan; 27(1):6-8. PubMed ID: 10682630 [TBL] [Abstract][Full Text] [Related]
17. [The research on p53 gene mutation in lung cancer tissue of silicotic patients by PCR-SSCR]. Zhou P; Liu B; Miao Q; Wang H Wei Sheng Yan Jiu; 1997 Sep; 26(5):293-5, 298. PubMed ID: 10325639 [TBL] [Abstract][Full Text] [Related]
18. [Detection of p53 gene mutation in paraffin-embedded asbestos-related lung cancer tissue]. Fu D; Liu B; Wang H Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Jul; 31(4):206-8. PubMed ID: 9812577 [TBL] [Abstract][Full Text] [Related]
19. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992 [TBL] [Abstract][Full Text] [Related]
20. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer. Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]